Novel α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid receptor (AMPAR) potentiator LT‐102: A promising therapeutic agent for treating cognitive impairment associated with schizophrenia.
Saved in:
| Title: | Novel α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid receptor (AMPAR) potentiator LT‐102: A promising therapeutic agent for treating cognitive impairment associated with schizophrenia. |
|---|---|
| Authors: | Qi, Xueyu1,2,3 (AUTHOR), Yu, Xueli1,2,3 (AUTHOR), Wei, Long1 (AUTHOR), Jiang, Han1 (AUTHOR), Dong, Jiangwen1 (AUTHOR), Li, Hongxing1 (AUTHOR), Wei, Yingying4 (AUTHOR), Zhao, Liansheng4 (AUTHOR), Deng, Wei1,2,3 (AUTHOR), Guo, Wanjun1,2,3 (AUTHOR), Hu, Xun5 (AUTHOR), Li, Tao1,2,3 (AUTHOR) litaozjusc@zju.edu.cn |
| Source: | CNS Neuroscience & Therapeutics. Apr2024, Vol. 30 Issue 4, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17555930 |
|---|---|
| DOI: | 10.1111/cns.14713 |
